Showing 261-270 of 2962 results for "".
- Health Canada Approves First Botulinum Toxin Type E for Aesthetic Usehttps://modernaesthetics.com/news/health-canada-approves-first-botulinum-toxin-type-e-for-aesthetic-use/2487591/Health Canada has approved Boey (trenibotulinumtoxinE; Allergan Aesthetics, an AbbVie company) for the temporary improvement in the appearance of moderate-to-severe glabellar lines in adult patients, making it the first approved botulinum neurotoxin serotype E for aesthetic use and the first rapi
- BOTOX Cosmetic Names 2026 Confidence Collective Entrepreneur Cohorthttps://modernaesthetics.com/news/botox-cosmetic-names-2026-confidence-collective-entrepreneur-cohort/2487577/Allergan Aesthetics, an AbbVie company, has announced the 2026 cohort for The Confidence Collective: Empowering Women Entrepreneurs, a BOTOX® Cosmetic initiative designed to support women business owners through mentorship, education, and funding opportunities. According to the company, th
- Global Integral Beauty Conference Marks Fifth Anniversary With Expanded International Programhttps://modernaesthetics.com/news/global-integral-beauty-conference-marks-fifth-anniversary-with-expanded-international-program/2487545/Global Integral Beauty (GIB) has announced that its 5th Global Integral Beauty Conference will be held on October 17, 2026, at the New York Marriott Marquis in New York, New York. Now entering its fifth year, the conference s
- Cellese Appoints Christopher Hausman as CEO to Lead Next Phase of Growth in Regenerative Aestheticshttps://modernaesthetics.com/news/cellese-appoints-christopher-hausman-as-ceo-to-lead-next-phase-of-growth-in-regenerative-aesthetics/2487520/Cellese Inc., the regenerative aesthetics company behind the AnteAGE® skincare brand, has appointed Christopher Hausman as Chief Executive Officer, the company announced. Hausman joins Irvine, California-based Cellese with more than 3 decades of experience in the aesthetics, skincare, dent
- Ludient Launches in US With AI-Driven Approach to Clinical Skincarehttps://modernaesthetics.com/news/ludient-launches-in-us-with-ai-driven-approach-to-clinical-skincare/2487480/Ludient, a clinical skincare brand developed by lululab, has officially launched in the United States, introducing an artificial intelligence (AI)-driven approach to skincare product development. According to the company, Ludient’s platform is powered by its proprietary luluTI™ technology,
- FDA Approves Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel for Midface Augmentationhttps://modernaesthetics.com/news/fda-approves-obagi-saypha-chiq-injectable-hyaluronic-acid-gel-for-midface-augmentation/2487470/Waldencast plc announced that the US Food and Drug Administration (FDA) has approved Obagi® saypha® ChIQ™ injectable hyaluronic acid (HA) gel, expanding the Obagi Medical injectable portfolio and strengthening the company’s position within the medical aesthetics market. According to the co
- Allergan Aesthetics Report Explores What Aesthetic Consumers Want Nowhttps://modernaesthetics.com/news/allergan-aesthetics-report-explores-what-aesthetic-consumers-want-now/2487442/Allergan Aesthetics, an AbbVie company, released "What Consumers Really Want," the latest installment in its The Aesthetics Evolution series, examining how consumer motivations, expectations, and perceptions of aesthetic care are changing. The report follows
- Preclinical Study Demonstrates Enhanced Skin Penetration of Natural Collagenhttps://modernaesthetics.com/news/preclinical-study-demonstrates-enhanced-skin-penetration-of-natural-collagen/2487422/A newly developed ginsenoside Rh2-based liposomal delivery system significantly improved the transdermal penetration of natural collagen and demonstrated skin-rejuvenating effects in a preclinical model of photoaging, according to research published online ahead of print in Langmuir.
- Review Examines Glycation’s Expanding Role in Cutaneous Aginghttps://modernaesthetics.com/news/review-examines-glycations-expanding-role-in-cutaneous-aging/2487357/A narrative review published in the Journal of Cosmetic Dermatology examines the growing evidence linking glycation and advanced glycation end products (AGEs) to skin aging, highlighting potential implications for both dermatology and aesthetic medicine. In the review, Diala Hayka
- Icon Skincare Launches Prestige Brand Focused on Simplicity, Confidence, and Ritualhttps://modernaesthetics.com/news/icon-skincare-launches-prestige-brand-focused-on-simplicity-confidence-and-ritual/2487304/Innovative Skincare, the company behind the global cosmeceutical brand iS Clinical, has announced the launch of Icon Skincare, a new prestige skincare line designed to simplify routines while emphasizing skin health, confidence, and daily ritual. Founded by Bryan Johns and Alec Call, Icon